III Scandinavian COPD research symposium  by Sköld, M. et al.
On November 14-15, 2008, the third Scandinavian COPD
Research Symposium was held at Holmenkollen Park
Hotel Rica, Oslo, Norway. Like the previous meetings,
arranged 2004 (1) and in 2006 (2), the purpose was to
let young scientists from our countries come together
and present their current COPD-related research. The
meeting should also facilitate collaboration and
stimulate further research in the field of COPD. For the
first time, Finland joined the symposium and eleven
young scientists from Denmark Finland, Norway and
Sweden presented their latest data and five State-of-
the-Art lecturers covered two sessions. “Inflammation
and structural changes in COPD’’ and “COPD – co-
morbidities’’. The meeting was generously supported by
grants from Boehringer-Ingelheim and Pfizer.
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ABSTRACTS — STATE OF THE ART
Inflammation in COPD
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The role of inflammation in the pathogenesis of COPD
has been emphasised during the last years, and this area
is now intensively researched. The current concept of
inflammation as a response to environmental noxious
agents, as cigarette smoke resulting in a local airway
inflammation is getting increasing evidence. However,
recently systemic inflammation has been studied, where
still the hen and egg debate between local and systemic
effects is ongoing.
The local inflammation in the airway is involving
innate and adaptive immune reactions. Throughout the
airway inflammatory reactions are seen, most well
studied in morphological samples of smokers with and
without COPD. In most patients there is a central
bronchitis seen, with inflammatory cells, hypertrophia
of mucous producing cells and glands. In the bronchioles
the inflammation can be intensive in spite of relatively
mild COPD. Emphysema can occur early in the develop-
ment of disease, and recently it has also been empha-
sised that there is often an intensive vascular inflam-
mation in COPD lungs. Most inflammatory cells are
recruited and activated in the airways of COPD patients.
The epithelium as the first resort for noxious agents is
activated, with certain pro-inflammatory activities.
Macrophages are recruited to both the airway paren-
chyma and perhaps more important to the airway
lumen, the obvious reason being phagocytosis particles
in the cigarette smoke. They also take part in the
further recruitment of inflammatory cells as neutro-
phils. Both macrophages and neutrophils produce pro-
teases, with important effects on the alveolar structure
during emphysema development. Both cell types also
produce oxygen radicals, which further enhances the
inflammatory reaction, and also decreases the ant-
protease activity in the airway. Lymphocyte reactions
seem to be abundant in the COPD inflammation, and the
number of cytotoxic T-lymphocytes(CD8 positive) is well
correlated to the severity of the disease, with early
changes also in the preclinical phase. A more recent
finding is that the adaptive immune system is involved
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